These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 15378507)

  • 1. Clinical relevance of immunophenotype in a retrospective comparative study of 297 peripheral T-cell lymphomas, unspecified, and 496 diffuse large B-cell lymphomas: experience of the Intergruppo Italiano Linformi.
    Morabito F; Gallamini A; Stelitano C; Callea V; Guglielmi C; Neri S; Lazzaro A; Orsucci L; Ilariucci F; Sacchi S; Vitolo U; Federico M
    Cancer; 2004 Oct; 101(7):1601-8. PubMed ID: 15378507
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Pathologic subtyping of primary lymphoma of breast and prognostic analysis].
    Zhou ZJ; Xie JL; Wei P; Zhou XG
    Zhonghua Bing Li Xue Za Zhi; 2017 Sep; 46(9):618-622. PubMed ID: 28910872
    [No Abstract]   [Full Text] [Related]  

  • 3. Prognostic significance of the aggregative perivascular growth pattern of tumor cells in primary central nervous system diffuse large B-cell lymphoma.
    He M; Zuo C; Wang J; Liu J; Jiao B; Zheng J; Cai Z
    Neuro Oncol; 2013 Jun; 15(6):727-34. PubMed ID: 23482670
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The prognostic significance of POD24 in peripheral T-cell lymphoma.
    Chen H; Ma R; Zhang Q; Lu F; Ma Y; Zhou J; Cao J; Qi K; Yan Z; Sang W; Zhu F; Sun H; Li D; Li Z; Cheng H; Xu K; Chen W
    Hematology; 2024 Dec; 29(1):2304483. PubMed ID: 38251872
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinicopathologic characteristics of angioimmunoblastic T-cell lymphoma: analysis of the international peripheral T-cell lymphoma project.
    Federico M; Rudiger T; Bellei M; Nathwani BN; Luminari S; Coiffier B; Harris NL; Jaffe ES; Pileri SA; Savage KJ; Weisenburger DD; Armitage JO; Mounier N; Vose JM
    J Clin Oncol; 2013 Jan; 31(2):240-6. PubMed ID: 22869878
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical significance and predictive risk factors for event-free survival at 24 months in patients with PTCL, NOS.
    Cao Z; Wang X; Xue X; Feng X
    Ann Hematol; 2024 Mar; 103(3):869-883. PubMed ID: 38040859
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of CD3+/CD20+ canine large-cell lymphoma.
    Howard CM; Anderson S; Harrington B
    J Vet Diagn Invest; 2024 Jan; 36(1):86-94. PubMed ID: 37837199
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hemoglobin-platelet index as a prognostic factor in patients with peripheral T-cell lymphoma.
    Yagi Y; Kanemasa Y; Sasaki Y; Okumura S; Watanabe T; Ishimine K; Hayashi Y; Mino M; Ohigashi A; Morita Y; Tamura T; Nakamura S; Okuya T; Shimoyama T
    EJHaem; 2023 Aug; 4(3):656-666. PubMed ID: 37601871
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Primary Thyroid Lymphoma: Clinical Factors Predicting the Possibility of Diffuse Large B-Cell Lymphoma.
    Kariya A; Tachibana T; Hiramatsu Y; Wani Y; Matsumoto JY; Furukawa C; Sato A; Naoi Y; Orita Y; Sato Y; Ando M
    Ear Nose Throat J; 2023 Dec; ():1455613231218130. PubMed ID: 38078418
    [No Abstract]   [Full Text] [Related]  

  • 10. Peripheral T-Cell Lymphomas Involving the Central Nervous System: A Report From the Czech Lymphoma Study Group Registry.
    Mocikova H; Pytlík R; Benesova K; Janikova A; Duras J; Sykorova A; Steinerova K; Prochazka V; Campr V; Belada D; Trneny M
    Front Oncol; 2022; 12():874462. PubMed ID: 35646641
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Primary colorectal diffuse large B-cell lymphoma: A report of eighteen cases in a tertiary care center.
    Vasconcelos FDC; Araujo ROC; Bernardo PS; Hancio T; de Moraes GN; Bigni RS; Valadão M; Pinto LW; Maia RC
    Cancer Treat Res Commun; 2023; 36():100722. PubMed ID: 37331034
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of the prognostic impact of IPI and PIT in peripheral T-cell lymphoma in real-world practice with a large elderly population.
    Nakamura N; Kanemura N; Matsumoto T; Nakamura H; Ikoma Y; Shibata Y; Kitagawa J; Kasahara S; Yamada T; Sawada M; Kaneda Y; Fukuno K; Takada E; Goto H; Lee S; Fujita K; Morishita T; Hara T; Tsurumi H; Shimizu M
    Sci Rep; 2023 Nov; 13(1):19060. PubMed ID: 37925551
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Prognostic Factors Affecting Recurrence in Peripheral T-Cell Lymphoma Patients with Different HDAC Levels].
    Li YX; Li YD; Wang P; Jiao HJ; Li Y; Zhang J; Yuan XH
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2024 Jun; 32(3):733-741. PubMed ID: 38926960
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic significance of 25-hydroxyvitamin D levels in patients with peripheral T-cell lymphoma.
    Park YG; Cho H; Kim S; Lee K; Ryu JS; Chae EJ; Kim KW; Park CS; Go H; Lee SW; Lee YS; Kwon M; Kim CW; Yoon DH
    Leuk Lymphoma; 2023 Dec; 64(12):1949-1955. PubMed ID: 37572015
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Flowcytometric data of intermediate-large cell gastrointestinal lymphoma presenting a gross mass in 32 cats - "let them glow in the flow".
    Rütgen BC; Wolfesberger B; Baumgartner D; Hammer SE; Groiss S; Hittmair KM; Gradner G; Fuchs-Baumgartinger A; Donovan TA; Schwendenwein I
    Front Vet Sci; 2024; 11():1378826. PubMed ID: 38863454
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Composite diffuse large B-cell lymphoma and peripheral T-cell lymphoma: a case report with two-year follow-up and literature review.
    Gu J; Qian J; Cao X
    Front Oncol; 2024; 14():1272209. PubMed ID: 38529384
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Extranodal diffuse large B-cell lymphomas: A retrospective case series and review of the literature.
    Boussios S; Zerdes I; Vassou A; Bareta E; Seraj E; Papoudou-Bai A; Pavlidis N; Batistatou A; Pentheroudakis G
    Hematol Rep; 2018 Mar; 10(1):7070. PubMed ID: 29721249
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased Serum Level of Interleukin-10 Predicts Poor Survival and Early Recurrence in Patients With Peripheral T-Cell Lymphomas.
    Zhang Y; Zheng Y; Shou L; Shi Y; Shen H; Zhu M; Ye X; Jin J; Xie W
    Front Oncol; 2020; 10():584261. PubMed ID: 33154947
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Incidence, Treatment, and Survival of Patients With T-Cell Lymphoma, T-Cell Large Granular Leukemia, and Concomitant Plasma Cell Dyscrasias.
    Braunstein Z; McLaughlin E; Ruiz M; Wei L; Bumma N; Benson D; Devarakonda S; Chaudhry M; Khan A; Cottini F; Hanel W; Baiocchi R; Chung C; Addison D; Couette N; Meara A; Jarjour W; Porcu P; Mishra A; Reneau JC; Rosko AE; Brammer JE
    Front Oncol; 2022; 12():858426. PubMed ID: 35574379
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predictors and Long-Term Outcomes for Diffuse Large B-Cell Lymphoma (DLBCL) Patients Undergoing Surgery Prior to Systemic Therapy: A Nationwide Analysis.
    Vusqa U; Jayakrishnan TT; Bakalov V; Chahine Z; Wegner R; Khan C; Fazal S; Samhouri Y; Malayala SV; Lister J
    Cureus; 2022 Apr; 14(4):e24448. PubMed ID: 35637830
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.